GAO Calls on FDA to Evaluate its Efforts on Least Burdensome Approach for Devices
By Michael Mezher -
Published 17 January 2018
The Government Accountability Office (GAO) has told the US Food and Drug Administration (FDA) to develop metrics to evaluate its performance in implementing its least burdensome approach to regulating medical devices, according to a report released on Tuesday.
Categories: News, US, CDRH, Medical Devices, Submission and registration
Tags: GAO, Government Accountability Office, Least Burdensome Provisions, FDAMA, 21st Century Cures